Articles
DEVELOPMENT OF AGARICUS BISPORUS AS A NUTRACEUTICAL OF TOMORROW
Article number
680_5
Pages
45 – 47
Language
English
Abstract
Agaricus bisporus (AB), the most popularly consumed mushroom was chosen to be developed into a nutraceutical product.
The important steps in the preparation of a nutraceutical i.e. standardization of processing method, its biological activity and safety index of the total extract were examined.
The hexane, methanolic and aqueous (cold and hot) extracts of AB dried at optimized temperatures was tested for their action on free radicals in Di phenyl Picryl Hydrazyl (DPPH) assay.
Finally, the safety of AB was established through in vivo tests up to a dose of 33 g/kg in mice.
The important steps in the preparation of a nutraceutical i.e. standardization of processing method, its biological activity and safety index of the total extract were examined.
The hexane, methanolic and aqueous (cold and hot) extracts of AB dried at optimized temperatures was tested for their action on free radicals in Di phenyl Picryl Hydrazyl (DPPH) assay.
Finally, the safety of AB was established through in vivo tests up to a dose of 33 g/kg in mice.
Publication
Authors
C. Gopalakrishnan, R.S. Pawar, K.K. Bhutani
Keywords
antioxidant, DPPH, ergosterol, vitamin D2
Online Articles (30)